Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Like Growth Factor I | 6 | 2014 | 55 | 1.880 |
Why?
|
| Fracture Healing | 6 | 2020 | 32 | 1.770 |
Why?
|
| Fractures, Bone | 5 | 2022 | 70 | 1.700 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 6 | 2015 | 28 | 1.280 |
Why?
|
| Gastric Bypass | 7 | 2020 | 67 | 1.230 |
Why?
|
| Joints | 4 | 2019 | 67 | 1.220 |
Why?
|
| Animals | 21 | 2022 | 3311 | 1.100 |
Why?
|
| Signal Transduction | 7 | 2022 | 402 | 0.980 |
Why?
|
| Obesity, Morbid | 5 | 2020 | 98 | 0.960 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2013 | 5 | 0.860 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2020 | 148 | 0.830 |
Why?
|
| Chondrocytes | 5 | 2019 | 103 | 0.790 |
Why?
|
| Receptors, Chemokine | 1 | 2022 | 9 | 0.790 |
Why?
|
| Mice | 12 | 2019 | 1249 | 0.780 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2014 | 15 | 0.740 |
Why?
|
| Weight Loss | 3 | 2020 | 122 | 0.710 |
Why?
|
| Cell Differentiation | 7 | 2020 | 125 | 0.650 |
Why?
|
| Homeostasis | 2 | 2022 | 65 | 0.640 |
Why?
|
| Bony Callus | 5 | 2022 | 6 | 0.630 |
Why?
|
| Protein Precursors | 1 | 2019 | 20 | 0.630 |
Why?
|
| Bone Diseases | 2 | 2010 | 20 | 0.620 |
Why?
|
| Interleukin-1 | 1 | 2019 | 48 | 0.610 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 30 | 0.610 |
Why?
|
| Mice, Knockout | 6 | 2019 | 283 | 0.590 |
Why?
|
| Cell Proliferation | 4 | 2014 | 165 | 0.580 |
Why?
|
| Body Mass Index | 2 | 2020 | 403 | 0.570 |
Why?
|
| Bone Marrow Cells | 2 | 2009 | 50 | 0.560 |
Why?
|
| Transforming Growth Factor beta | 3 | 2007 | 82 | 0.550 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2015 | 43 | 0.540 |
Why?
|
| Stem Cells | 3 | 2013 | 34 | 0.530 |
Why?
|
| Cartilage Diseases | 2 | 2008 | 47 | 0.490 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 9 | 0.470 |
Why?
|
| Osteoarthritis | 1 | 2019 | 289 | 0.460 |
Why?
|
| Organogenesis | 1 | 2015 | 2 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 5 | 2015 | 364 | 0.420 |
Why?
|
| Osteoblasts | 1 | 2014 | 52 | 0.420 |
Why?
|
| Osteosarcoma | 1 | 2014 | 40 | 0.420 |
Why?
|
| Foot Joints | 1 | 2013 | 4 | 0.400 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2012 | 1 | 0.390 |
Why?
|
| Morphogenesis | 2 | 2015 | 8 | 0.390 |
Why?
|
| Growth Plate | 1 | 2012 | 13 | 0.380 |
Why?
|
| Regenerative Medicine | 2 | 2012 | 4 | 0.380 |
Why?
|
| Bone Regeneration | 2 | 2009 | 69 | 0.370 |
Why?
|
| Humans | 21 | 2020 | 23569 | 0.350 |
Why?
|
| Serum Albumin, Bovine | 1 | 2010 | 5 | 0.330 |
Why?
|
| Genetic Therapy | 1 | 2010 | 83 | 0.330 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 16 | 0.320 |
Why?
|
| Adipose Tissue | 3 | 2018 | 73 | 0.320 |
Why?
|
| Proteins | 1 | 2010 | 54 | 0.320 |
Why?
|
| Tibial Fractures | 1 | 2009 | 7 | 0.320 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 293 | 0.310 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 36 | 0.300 |
Why?
|
| Bone and Bones | 3 | 2018 | 109 | 0.290 |
Why?
|
| Obesity | 3 | 2020 | 294 | 0.290 |
Why?
|
| Neoplasms | 1 | 2010 | 223 | 0.280 |
Why?
|
| Female | 13 | 2020 | 13266 | 0.280 |
Why?
|
| Biomarkers | 2 | 2020 | 482 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2005 | 5 | 0.260 |
Why?
|
| Mesoderm | 2 | 2005 | 18 | 0.260 |
Why?
|
| Chondrogenesis | 1 | 2006 | 24 | 0.250 |
Why?
|
| Apoptosis | 2 | 2004 | 198 | 0.240 |
Why?
|
| Bone Density | 2 | 2020 | 139 | 0.240 |
Why?
|
| Male | 10 | 2020 | 12776 | 0.220 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 37 | 0.220 |
Why?
|
| Cartilage, Articular | 3 | 2013 | 279 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2013 | 472 | 0.210 |
Why?
|
| Somatomedins | 1 | 2003 | 4 | 0.210 |
Why?
|
| Rodentia | 1 | 2022 | 6 | 0.200 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 21 | 0.200 |
Why?
|
| Prospective Studies | 4 | 2020 | 1535 | 0.190 |
Why?
|
| Stem Cell Niche | 2 | 2013 | 2 | 0.190 |
Why?
|
| Cell Movement | 2 | 2014 | 77 | 0.190 |
Why?
|
| Adiponectin | 2 | 2012 | 10 | 0.190 |
Why?
|
| Omentum | 2 | 2012 | 7 | 0.190 |
Why?
|
| X-Ray Microtomography | 2 | 2012 | 73 | 0.190 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 169 | 0.180 |
Why?
|
| Aging | 2 | 2019 | 1101 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 60 | 0.170 |
Why?
|
| Postoperative Period | 2 | 2019 | 269 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2019 | 505 | 0.160 |
Why?
|
| Osteoclasts | 1 | 2020 | 20 | 0.160 |
Why?
|
| Middle Aged | 8 | 2020 | 8155 | 0.160 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 51 | 0.160 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2019 | 4 | 0.160 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2019 | 19 | 0.160 |
Why?
|
| Preoperative Period | 1 | 2019 | 68 | 0.150 |
Why?
|
| Transcription Factors | 2 | 2014 | 149 | 0.150 |
Why?
|
| Analysis of Variance | 1 | 2019 | 235 | 0.150 |
Why?
|
| Injections, Intra-Articular | 1 | 2019 | 58 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2019 | 91 | 0.150 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 24 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2019 | 144 | 0.140 |
Why?
|
| Phenotype | 1 | 2019 | 261 | 0.140 |
Why?
|
| Comorbidity | 1 | 2019 | 431 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 29 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2019 | 3095 | 0.140 |
Why?
|
| Adult | 6 | 2020 | 7178 | 0.140 |
Why?
|
| Kidney | 1 | 2018 | 144 | 0.140 |
Why?
|
| Disease Progression | 1 | 2019 | 530 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 155 | 0.130 |
Why?
|
| Adipocytes | 2 | 2012 | 22 | 0.120 |
Why?
|
| Cell Separation | 1 | 2015 | 21 | 0.120 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1493 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 248 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2012 | 48 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2020 | 837 | 0.110 |
Why?
|
| Sp7 Transcription Factor | 1 | 2014 | 1 | 0.110 |
Why?
|
| Proteasome Inhibitors | 1 | 2014 | 2 | 0.110 |
Why?
|
| Leupeptins | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2014 | 6 | 0.110 |
Why?
|
| Mice, Nude | 1 | 2014 | 25 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 21 | 0.110 |
Why?
|
| RNA Interference | 1 | 2014 | 36 | 0.110 |
Why?
|
| Osteocalcin | 1 | 2014 | 25 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 95 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 32 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 76 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2014 | 131 | 0.100 |
Why?
|
| Models, Biological | 1 | 2015 | 305 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 114 | 0.100 |
Why?
|
| Forelimb | 1 | 2013 | 5 | 0.100 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 10 | 0.100 |
Why?
|
| Synovial Membrane | 1 | 2013 | 47 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 176 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 49 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 179 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2012 | 50 | 0.090 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 8 | 0.090 |
Why?
|
| Leptin | 1 | 2011 | 18 | 0.090 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.090 |
Why?
|
| Cell Migration Assays | 1 | 2011 | 1 | 0.090 |
Why?
|
| Retroviridae | 1 | 2011 | 5 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 17 | 0.090 |
Why?
|
| Time Factors | 1 | 2015 | 1295 | 0.090 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 40 | 0.090 |
Why?
|
| Transfection | 1 | 2011 | 117 | 0.090 |
Why?
|
| Wound Healing | 1 | 2012 | 123 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2011 | 55 | 0.090 |
Why?
|
| Pregnancy | 1 | 2012 | 322 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 74 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 129 | 0.090 |
Why?
|
| Regeneration | 1 | 2010 | 15 | 0.090 |
Why?
|
| Osteogenesis | 1 | 2011 | 101 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 556 | 0.080 |
Why?
|
| Cholic Acids | 1 | 2010 | 1 | 0.080 |
Why?
|
| Hindlimb | 1 | 2010 | 15 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 22 | 0.080 |
Why?
|
| Chitosan | 1 | 2010 | 9 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2010 | 10 | 0.080 |
Why?
|
| Cattle | 1 | 2010 | 112 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2009 | 22 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2009 | 6 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 17 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Extremities | 1 | 2007 | 24 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2004 | 50 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 135 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 231 | 0.050 |
Why?
|
| Cell Line | 1 | 2003 | 250 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2020 | 28 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 51 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 196 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 30 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2020 | 185 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2012 | 1466 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2012 | 8 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2012 | 23 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 14 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 37 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 78 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 3122 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 200 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 285 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 233 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 7586 | 0.020 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 38 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 81 | 0.010 |
Why?
|